GB9309161D0 - Footrot antigens,vaccines and diagnostic assays - Google Patents

Footrot antigens,vaccines and diagnostic assays

Info

Publication number
GB9309161D0
GB9309161D0 GB939309161A GB9309161A GB9309161D0 GB 9309161 D0 GB9309161 D0 GB 9309161D0 GB 939309161 A GB939309161 A GB 939309161A GB 9309161 A GB9309161 A GB 9309161A GB 9309161 D0 GB9309161 D0 GB 9309161D0
Authority
GB
United Kingdom
Prior art keywords
footrot
vaccines
antigens
diagnostic assays
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939309161A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of GB9309161D0 publication Critical patent/GB9309161D0/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB939309161A 1992-05-01 1993-04-30 Footrot antigens,vaccines and diagnostic assays Pending GB9309161D0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPL222692 1992-05-01
AUPL344592 1992-07-10
AUPL470892 1992-09-14
AUPL471192 1992-09-14
AUPL628492 1992-12-10
AUPL682793 1993-01-14

Publications (1)

Publication Number Publication Date
GB9309161D0 true GB9309161D0 (en) 1993-06-16

Family

ID=27542942

Family Applications (2)

Application Number Title Priority Date Filing Date
GB939309161A Pending GB9309161D0 (en) 1992-05-01 1993-04-30 Footrot antigens,vaccines and diagnostic assays
GB9309159A Expired - Fee Related GB2267148B (en) 1992-05-01 1993-05-04 Footrot antigens,vaccines and diagnostic assays

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9309159A Expired - Fee Related GB2267148B (en) 1992-05-01 1993-05-04 Footrot antigens,vaccines and diagnostic assays

Country Status (2)

Country Link
GB (2) GB9309161D0 (en)
NZ (1) NZ247535A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003264590B2 (en) * 2002-12-19 2005-07-21 The University Of New England Determining virulence of bacteria
AU2007335254A1 (en) * 2006-12-21 2008-06-26 Monash University Identification of candidate vaccine antigens from Dichelobacter nodosus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU580825B2 (en) * 1984-12-24 1989-02-02 Commonwealth Scientific And Industrial Research Organisation Bacteroides nodosus vaccine
AU614754B2 (en) * 1987-06-05 1991-09-12 Commonwealth Scientific And Industrial Research Organisation Treatment and diagnosis of footrot using the basic protease of b.nodosus.

Also Published As

Publication number Publication date
NZ247535A (en) 1995-10-26
GB9309159D0 (en) 1993-06-16
GB2267148B (en) 1996-12-04
GB2267148A (en) 1993-11-24

Similar Documents

Publication Publication Date Title
EP0636029A4 (en) Antibodies specific for carcinoma-associated antigens.
AU2843889A (en) Antigen antibody conjugate
AU5999490A (en) Chimeric antibodies directed against a human glycoprotein antigen
NZ222981A (en) 2'-deoxy-2'2'-difluoronucleosides, antibody conjugates and pharmaceuticals containing the conjugates
EP0676966A4 (en) Antibodies directed against binding-associated epitopes.
EP0634019A4 (en) Immunoassays employing generic anti-hapten antibodies and materials for use therein.
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
EP0878541A4 (en) Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
IL109445A0 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
IL101201A0 (en) Methods for selecting antibody reagents,anti-idiotype antibodies and aids vaccine formulations
GB2267148B (en) Footrot antigens,vaccines and diagnostic assays
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
AU3829189A (en) Detecting antigens or antibodies
AU3837793A (en) Footrot antigens, vaccines and diagnostic assays
AU2412692A (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
AU1135595A (en) Saccharomyces-specific antigens and antibodies, their preparation and use
GB9014652D0 (en) Antigen
AU3432389A (en) Human monoclonal antibodies against rabies virus
AU4863490A (en) Polypeptides, antigens or vaccines protective against babesiosis
IL94304A0 (en) Novel tumor-associated antigen,antibodies,compositions and uses therefor
GB2238959B (en) Antigen and conjugates thereof for suppressing immune response
EP0446763A3 (en) Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
AU4996193A (en) Pfemp3 malaria antigen, analogs, antibodies and uses thereof